Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

redifferentiation

  • You have access
    Current Treatment Strategies in Metastasized Differentiated Thyroid Cancer
    Michael C. Kreissl, Marcel J.R. Janssen and James Nagarajah
    Journal of Nuclear Medicine January 1, 2019, 60 (1) 9-15; DOI: https://doi.org/10.2967/jnumed.117.190819
  • You have access
    Iodine Symporter Targeting with 124I/131I Theranostics
    James Nagarajah, Marcel Janssen, Philipp Hetkamp and Walter Jentzen
    Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 34S-38S; DOI: https://doi.org/10.2967/jnumed.116.186866
  • You have access
    Antitumor Effects of Proteasome Inhibition in Anaplastic Thyroid Carcinoma
    Annette Altmann, Annette Markert, Vasileios Askoxylakis, Tilman Schöning, Ralf Jesenofsky, Michael Eisenhut and Uwe Haberkorn
    Journal of Nuclear Medicine November 1, 2012, 53 (11) 1764-1771; DOI: https://doi.org/10.2967/jnumed.111.101295
SNMMI

© 2025 SNMMI

Powered by HighWire